These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38849479)

  • 1. Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
    Owaki T; Iida T; Miyai Y; Kato K; Hase T; Ishii M; Ando R; Hinohara K; Akashi T; Mizutani Y; Ishikawa T; Mii S; Shiraki Y; Esaki N; Yamamoto M; Tsukamoto T; Nomura S; Murakami T; Takahashi M; Yuguchi Y; Maeda M; Sano T; Sassa N; Matsukawa Y; Kawashima H; Akamatsu S; Enomoto A
    Br J Cancer; 2024 Jul; 131(2):372-386. PubMed ID: 38849479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma.
    Mizutani Y; Iida T; Ohno E; Ishikawa T; Kinoshita F; Kuwatsuka Y; Imai M; Shimizu S; Tsuruta T; Enomoto A; Kawashima H; Fujishiro M
    BMC Cancer; 2022 Feb; 22(1):205. PubMed ID: 35209871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade.
    Miyai Y; Sugiyama D; Hase T; Asai N; Taki T; Nishida K; Fukui T; Chen-Yoshikawa TF; Kobayashi H; Mii S; Shiraki Y; Hasegawa Y; Nishikawa H; Ando Y; Takahashi M; Enomoto A
    Life Sci Alliance; 2022 Jun; 5(6):. PubMed ID: 35236758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.
    Shimizu D; Yuge R; Kitadai Y; Ariyoshi M; Miyamoto R; Hiyama Y; Takigawa H; Urabe Y; Oka S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma.
    Li J; Chen M; Tong M; Cao Q
    Front Immunol; 2024; 15():1457691. PubMed ID: 39301023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics.
    Iida T; Mizutani Y; Esaki N; Ponik SM; Burkel BM; Weng L; Kuwata K; Masamune A; Ishihara S; Haga H; Kataoka K; Mii S; Shiraki Y; Ishikawa T; Ohno E; Kawashima H; Hirooka Y; Fujishiro M; Takahashi M; Enomoto A
    Oncogene; 2022 May; 41(19):2764-2777. PubMed ID: 35414659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer.
    Anandhan S; Herbrich S; Goswami S; Guan B; Chen Y; Macaluso MD; Jindal S; Natarajan SM; Andrewes SW; Xiong L; Nagarajan A; Basu S; Tang DN; Liu J; Min J; Maitra A; Sharma P
    Nat Commun; 2024 Jul; 15(1):5291. PubMed ID: 38987547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the potential: Targeting metabolic pathways in the tumor microenvironment for Cancer therapy.
    Jia S; Bode AM; Chen X; Luo X
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189166. PubMed ID: 39111710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting MS4A4A: A novel pathway to improve immunotherapy responses in glioblastoma.
    Shao G; Cui X; Wang Y; Luo S; Li C; Jiang Y; Cai D; Li N; Li X
    CNS Neurosci Ther; 2024 Jul; 30(7):e14791. PubMed ID: 38997808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.
    Jenkins L; Jungwirth U; Avgustinova A; Iravani M; Mills A; Haider S; Harper J; Isacke CM
    Cancer Res; 2022 Aug; 82(16):2904-2917. PubMed ID: 35749591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma.
    McGregor BA; Lalani AA; Xie W; Steinharter JA; E Bakouny Z; Martini DJ; Fleischer JH; Abou-Alaiwi S; Nassar A; Nuzzo PV; Kaymakcalan MD; Braun DA; Wei XX; Harshman LC; Bilen MA; Choueiri TK
    Eur J Cancer; 2020 Aug; 135():203-210. PubMed ID: 32599410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD
    Yang M; Wang B; Hou W; Zeng H; He W; Zhang XK; Yan D; Yu H; Huang L; Pei L; Li K; Qin H; Lin T; Huang J
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 39067875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1
    Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D
    Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma.
    Shu G; Chen M; Liao W; Fu L; Lin M; Gui C; Cen J; Lu J; Chen Z; Wei J; Chen W; Wang Y; Zhu J; Zhao T; Liu X; Jing J; Liu GC; Pan Y; Luo J; Zhang J
    Cancer Res; 2024 May; 84(10):1659-1679. PubMed ID: 38382068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
    Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
    Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
    BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactate-induced activation of tumor-associated fibroblasts and IL-8-mediated macrophage recruitment promote lung cancer progression.
    Gu X; Zhu Y; Su J; Wang S; Su X; Ding X; Jiang L; Fei X; Zhang W
    Redox Biol; 2024 Aug; 74():103209. PubMed ID: 38861833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.